NT-69

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNT-69

Drug Alias Nameneurotensin agonists (Sarentis Therapeutics)neurotensin agonists (Sarentis Therapeutics)neurotensin receptor modulators (Sarentis)NT-69

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionNeurotensin receptors agonists

TargetsNeurotensin receptors

Therapy Area/IndicationsEye Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSarentis Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSarentis Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsEye Pain

Other Information

ATC CodeN/A